Hakan Büyükhatipoğlu

1.1k total citations
64 papers, 793 citations indexed

About

Hakan Büyükhatipoğlu is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Hakan Büyükhatipoğlu has authored 64 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Cardiology and Cardiovascular Medicine and 13 papers in Surgery. Recurrent topics in Hakan Büyükhatipoğlu's work include Renin-Angiotensin System Studies (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). Hakan Büyükhatipoğlu is often cited by papers focused on Renin-Angiotensin System Studies (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). Hakan Büyükhatipoğlu collaborates with scholars based in Türkiye and United Kingdom. Hakan Büyükhatipoğlu's co-authors include Yusuf Sezen, Merve Savaş, İlkay Şımşek, Celalettin Usalan, Abdurrahman Kadayıfçı, Ahmet Mesut Onat, Turgay Ulaş, Ersin Akarsu, Mehmet Bekerecioğlu and Mustafa Tercan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of General Internal Medicine.

In The Last Decade

Hakan Büyükhatipoğlu

61 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hakan Büyükhatipoğlu Türkiye 16 230 135 132 92 85 64 793
Tsutomu Hashimoto Japan 20 389 1.7× 108 0.8× 148 1.1× 71 0.8× 110 1.3× 53 921
Chen‐Yu Chien Taiwan 18 242 1.1× 106 0.8× 58 0.4× 57 0.6× 165 1.9× 59 993
Pedram Paragomi United States 17 268 1.2× 72 0.5× 74 0.6× 122 1.3× 89 1.0× 59 899
Sebahat Özdem Türkiye 17 190 0.8× 71 0.5× 62 0.5× 72 0.8× 133 1.6× 74 746
C. E. Fiore Italy 19 182 0.8× 178 1.3× 243 1.8× 114 1.2× 267 3.1× 48 1.2k
Cumhur Yeğen Türkiye 20 691 3.0× 217 1.6× 160 1.2× 131 1.4× 65 0.8× 103 1.2k
Sibel Bektaş Türkiye 22 365 1.6× 195 1.4× 123 0.9× 78 0.8× 195 2.3× 82 1.2k
Ayşe Balat Türkiye 18 201 0.9× 172 1.3× 52 0.4× 94 1.0× 196 2.3× 99 1.1k
Stanley Sau Ching Wong Hong Kong 18 381 1.7× 165 1.2× 71 0.5× 36 0.4× 187 2.2× 64 1.0k
Krystyna Sztefko Poland 21 274 1.2× 97 0.7× 63 0.5× 171 1.9× 314 3.7× 106 1.2k

Countries citing papers authored by Hakan Büyükhatipoğlu

Since Specialization
Citations

This map shows the geographic impact of Hakan Büyükhatipoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Büyükhatipoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Büyükhatipoğlu more than expected).

Fields of papers citing papers by Hakan Büyükhatipoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakan Büyükhatipoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Büyükhatipoğlu. The network helps show where Hakan Büyükhatipoğlu may publish in the future.

Co-authorship network of co-authors of Hakan Büyükhatipoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Hakan Büyükhatipoğlu. A scholar is included among the top collaborators of Hakan Büyükhatipoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakan Büyükhatipoğlu. Hakan Büyükhatipoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarici, Furkan, Taner Babacan, Hakan Büyükhatipoğlu, et al.. (2017). Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience.. PubMed. 21(4). 826–831.
2.
Süner, Ali, Hakan Büyükhatipoğlu, Gökmen Aktaş, et al.. (2016). Polymorphisms in the <em>MTHFR</em> gene are associated with recurrence risk in lymph node-positive breast cancer patients. OncoTargets and Therapy. Volume 9. 5603–5609. 1 indexed citations
3.
Babacan, Taner, Orhan Efe, Hakan Büyükhatipoğlu, et al.. (2015). Efficacy of Capecitabine Monotherapy as the First-line Treatment of Metastatic HER2-negative Breast Cancer. Tumori Journal. 101(4). 418–423. 8 indexed citations
4.
Büyükhatipoğlu, Hakan, Taner Babacan, Neyran Kertmen, et al.. (2015). A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer.. PubMed. 20(1). 22–7. 5 indexed citations
5.
Babacan, Taner, Hakan Büyükhatipoğlu, Neyran Kertmen, et al.. (2015). Chemotherapy might not be beneficial in lymph node- negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis.. PubMed. 20(2). 479–86. 2 indexed citations
6.
Büyükhatipoğlu, Hakan, Ali Süner, Alper Sevinç, et al.. (2014). Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey. Journal of Cancer Research and Therapeutics. 10(4). 962–962. 17 indexed citations
7.
Ulaş, Turgay, et al.. (2012). Rapid improvement of Henoch-Schonlein purpura associated with the treatment of Helicobacter pylori infection.. PubMed. 17(11). 1086–8. 6 indexed citations
8.
Büyükhatipoğlu, Hakan, et al.. (2011). Increased urotensin-II activity in patients with Raynaud’s phenomenon and systemic lupus erythematosus. International Journal of Rheumatic Diseases. 14(3). 276–281. 2 indexed citations
9.
Büyükhatipoğlu, Hakan, et al.. (2010). Acute renal failure with the combined use of rosuvastatin and fenofibrate. Renal Failure. 32(5). 633–635. 5 indexed citations
10.
Büyükhatipoğlu, Hakan, et al.. (2010). Plasma Plasminogen Activator Inhibitor 1 (PAI-1) and p-Selectin Levels in Urgent Hypertension: Effect of Single Dose Captopril and Nifedipin on Fibrinolytic Activity. Clinical and Experimental Hypertension. 32(6). 347–351. 6 indexed citations
11.
12.
Büyükhatipoğlu, Hakan, et al.. (2010). Oxidative Stress Increased in Healthcare Workers Working 24-Hour On-Call Shifts. The American Journal of the Medical Sciences. 340(6). 462–467. 37 indexed citations
13.
14.
Büyükhatipoğlu, Hakan, et al.. (2009). Impaired Fibrinolytic and Blunted Nitric Oxide Response to Phlebotomy in Cigarette Smoking Healthy Blood Donors. Journal of International Medical Research. 37(3). 674–679. 4 indexed citations
15.
Erkutlu, İbrahim, et al.. (2008). Where is the Brain Paranchyme? "Primary cerebral multiple cyst hydatid". Internal Medicine. 47(4). 333–333. 1 indexed citations
16.
Büyükhatipoğlu, Hakan, et al.. (2007). Successful Treatment of a Rare Complication of HenochSchoenlein Purpura in Advanced Age: Pulmonary Hemorrhage. Internal Medicine. 46(12). 905–907. 7 indexed citations
17.
Yılmaz, Mehmet Birhan, Vahap Okan, Mustafa Pehlıvan, et al.. (2007). A case report of POEMS syndrome developing during the clinical course of immune thrombocytopenic purpura. Platelets. 18(7). 540–542. 5 indexed citations
18.
Kadayıfçı, Abdurrahman, Hakan Büyükhatipoğlu, Merve Savaş, & İlkay Şımşek. (2006). Eradication of Helicobacter pylori with triple therapy:An epidemiologic analysis of trends in Turkey over 10 years. Clinical Therapeutics. 28(11). 1960–1966. 74 indexed citations
19.
Büyükhatipoğlu, Hakan, et al.. (2006). Takayasu arteritis: association with focal segmental glomerulosclerosis. Clinical Rheumatology. 26(4). 609–611. 3 indexed citations
20.
Yılmaz, Mehmet Birhan, et al.. (2006). Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto’s disease) mimicking systemic lupus erythematosus: a review of two cases. Lupus. 15(6). 384–387. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsutomu Hashimoto Breakdown of academic impact, for papers by Chen‐Yu Chien Breakdown of academic impact, for papers by Pedram Paragomi Breakdown of academic impact, for papers by Sebahat Özdem Breakdown of academic impact, for papers by C. E. Fiore Breakdown of academic impact, for papers by Cumhur Yeğen Breakdown of academic impact, for papers by Sibel Bektaş Breakdown of academic impact, for papers by Ayşe Balat Breakdown of academic impact, for papers by Stanley Sau Ching Wong Breakdown of academic impact, for papers by Krystyna Sztefko
Rankless by CCL
2026